179 related articles for article (PubMed ID: 37800876)
21. Serum Calcium, 25-Hydroxyvitamin D, and Parathyroid Hormone Levels in Relation to Aneurysmal Subarachnoid Hemorrhage.
Zhang Z; Yuan S; Larsson SC; Wang M; Liu X
Mol Neurobiol; 2023 Jun; 60(6):3004-3009. PubMed ID: 36764983
[TBL] [Abstract][Full Text] [Related]
22. Genetically determined blood pressure, antihypertensive drug classes, and risk of stroke subtypes.
Georgakis MK; Gill D; Webb AJS; Evangelou E; Elliott P; Sudlow CLM; Dehghan A; Malik R; Tzoulaki I; Dichgans M
Neurology; 2020 Jul; 95(4):e353-e361. PubMed ID: 32611631
[TBL] [Abstract][Full Text] [Related]
23. Circulating inflammatory biomarkers and risk of intracranial aneurysm: a Mendelian randomization study.
Fang J; Cao Y; Ni J
Eur J Med Res; 2024 Jan; 29(1):17. PubMed ID: 38173028
[TBL] [Abstract][Full Text] [Related]
24. Causal relationships between human blood metabolites and intracranial aneurysm and aneurysmal subarachnoid hemorrhage: a Mendelian randomization study.
Jiang J; Gui S; Wei D; Chen X; Tang Y; Lv J; You W; Chen T; Yang S; Ge H; Li Y
Front Neurol; 2023; 14():1268138. PubMed ID: 38162442
[TBL] [Abstract][Full Text] [Related]
25. Genetically Predicted Blood Pressure and Risk of Atrial Fibrillation.
Hyman MC; Levin MG; Gill D; Walker VM; Georgakis MK; Davies NM; Marchlinski FE; Damrauer SM
Hypertension; 2021 Feb; 77(2):376-382. PubMed ID: 33390040
[TBL] [Abstract][Full Text] [Related]
26. Genetically Determined Smoking Behavior and Risk of Nontraumatic Subarachnoid Hemorrhage.
Acosta JN; Szejko N; Both CP; Vanent K; Noche RB; Gill TM; Matouk CC; Sheth KN; Gunel M; Falcone GJ
Stroke; 2021 Jan; 52(2):582-587. PubMed ID: 33440997
[TBL] [Abstract][Full Text] [Related]
27. First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension.
Xue H; Lu Z; Tang WL; Pang LW; Wang GM; Wong GW; Wright JM
Cochrane Database Syst Rev; 2015 Jan; 1():CD008170. PubMed ID: 25577154
[TBL] [Abstract][Full Text] [Related]
28. Causal Association between Tea Intake and Acute Cerebrovascular Events: A Multivariate Mendelian Randomized Study in European Populations.
Deng X; Lai R; Zhu J; Liang J; Chang W; Lv X; Gong L; Cai Y; Liu S
J Nutr; 2024 Jan; 154(1):79-86. PubMed ID: 37951389
[TBL] [Abstract][Full Text] [Related]
29. Genetically predicted coffee and tea consumption and risk of intracranial aneurysm.
Zhang Z; Wang M; Yuan S; Larsson SC; Liu X
Eur J Clin Nutr; 2023 Aug; 77(8):811-814. PubMed ID: 37311867
[TBL] [Abstract][Full Text] [Related]
30. Genetically predicted tobacco consumption and risk of intracranial aneurysm: a Mendelian randomization study.
Zeng C; Huang Z; Tao W; Yan L; Tang D; Chen F; Li S
Environ Sci Pollut Res Int; 2023 Jan; 30(5):12979-12987. PubMed ID: 36117221
[TBL] [Abstract][Full Text] [Related]
31. Protective effect of antihypertensive drugs on the risk of Parkinson's disease lacks causal evidence from mendelian randomization.
Jiang Z; Gu XJ; Su WM; Duan QQ; Ren YL; Li JR; Chi LY; Wang Y; Cao B; Chen YP
Front Pharmacol; 2023; 14():1107248. PubMed ID: 36909159
[No Abstract] [Full Text] [Related]
32. Mood swings are causally associated with intracranial aneurysm subarachnoid hemorrhage: A Mendelian randomization study.
Peng K; Li Y; Adegboro AA; Wanggou S; Li X
Brain Behav; 2023 Nov; 13(11):e3233. PubMed ID: 37632147
[TBL] [Abstract][Full Text] [Related]
33. Regular medication as a risk factor for intracranial aneurysms: A comparative case-control study.
Jabbarli R; Darkwah Oppong M; Chihi M; Dinger TF; Said M; Rodemerk J; Dammann P; Schmidt B; Deuschl C; Guberina N; Wrede KH; Sure U
Eur Stroke J; 2023 Mar; 8(1):251-258. PubMed ID: 37021158
[TBL] [Abstract][Full Text] [Related]
34. Association of antihypertensive drugs with COVID-19 outcomes: a drug-target Mendelian randomization study.
Zhang K; Gao H; Chen M
Front Pharmacol; 2023; 14():1224737. PubMed ID: 38116083
[No Abstract] [Full Text] [Related]
35. Genetic Causal Association Between the Gut Microbiome and Intracranial Aneurysm and Subarachnoid Hemorrhage: A Two-Sample Mendelian Randomization Study.
He M; Wang W; He Q; Dai H; Han J; Cui W
Neurol Ther; 2023 Oct; 12(5):1695-1707. PubMed ID: 37440166
[TBL] [Abstract][Full Text] [Related]
36. Causal association between depression and intracranial aneurysms: a bidirectional two-sample Mendelian randomization study.
Wu J; Sun H; Ma J
Front Neurol; 2024; 15():1346703. PubMed ID: 38419712
[TBL] [Abstract][Full Text] [Related]
37. [Assessment of antihypertensive monotherapies effectiveness by home blood pressure self-measurement in hypertensive patients].
Hanon O; Laroche P; Vidal JS; Pannier B; Postel-Vinay N; Vaisse B; Girerd X
Ann Cardiol Angeiol (Paris); 2012 Jun; 61(3):218-23. PubMed ID: 22695025
[TBL] [Abstract][Full Text] [Related]
38. Hypertension, antihypertensive drugs, and age at onset of Huntington's disease.
Zhu Y; Li M; Bai J; Wang H; Huang X
Orphanet J Rare Dis; 2023 May; 18(1):125. PubMed ID: 37226269
[TBL] [Abstract][Full Text] [Related]
39. Modifiable risk factors for intracranial aneurysms: Evidence from genetic studies.
Sun X; Liu B; Chen Y; Lv L; Ye D; Mao Y
Int J Stroke; 2022 Dec; 17(10):1107-1113. PubMed ID: 36408635
[TBL] [Abstract][Full Text] [Related]
40. Role of antihypertensive therapy with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers in combination with calcium channel blockers for stroke prevention.
Talbert RL
J Am Pharm Assoc (2003); 2010; 50(5):e116-25. PubMed ID: 20833609
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]